Document is current
Any future updates will be listed below
-
Authors
Roberts, Derek J. http://orcid.org/0000-0001-6111-6291
Faris, Peter D.
Ball, Chad G.
Kirkpatrick, Andrew W.
Moore, Ernest E.
Feliciano, David V.
Rhee, Peter
D’Amours, Scott
Stelfox, Henry T.
-
Funding
Funding for this research was provided by:
alberta innovates - health solutions
canadian institutes of health research
knowledge translation canada
- License Information
-
More Information
Article History
Received: 17 July 2021
Accepted: 19 September 2021
First Online: 14 October 2021
Declarations
:
: The University of Calgary Conjoint Health Research Ethics Board approved the study. Consent to participate in the study was implied with survey completion.
: Not applicable.
: Dr. Kirkpatrick has consulted for Zoll, Innovative Trauma Care, CSL Behring, and SAM Medical Corporations, and is the principal investigator for a randomized controlled trial partially supported by Acelity Corporation. Dr. Moore receives research support from Haemonetics, Instrumentation Laboratory, Hemosonics, Diapharma, Humacyte, and Genetech. He is also the cofounder of ThromboTherapeutics. The other authors have no conflicts of interest to declare.
